Markets:

Overview

News

Currencies

International

Treasuries

Cogent Biosciences, Inc. - Common Stock (NQ:COGT)

38.48 -0.22 (-0.57%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cogent Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Trump Tariffs Sink Dow Over 400 Points: Investor Sentiment Declines, But Fear & Greed Index Remains In 'Extreme Greed' Zone ↗

July 08, 2025

Via Benzinga

Topics Government Stocks

Dow Dips 1%; Mustang Bio Shares Spike Higher ↗

July 07, 2025

Via Benzinga

Topics Stocks

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

July 07, 2025

Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

KalVista Pharmaceuticals, Cogent Biosciences, WNS And Other Big Stocks Moving Higher On Monday ↗

July 07, 2025

Via Benzinga

Why Is Cogent Biosciences Stock Trading Higher On Monday? ↗

December 09, 2024

Cogent Biosciences' SUMMIT trial shows bezuclastinib improves symptoms and quality of life in systemic mastocytosis, with favorable safety data.

Via Benzinga

Cogent Biosciences Inc. (NASDAQ: COGT) Leading the Way in Wednesday Trading Based on Percentage Gain

February 14, 2024

Via Investor Brand Network

Why Is Cogent Biosciences Stock Trading Higher On Monday? ↗

July 07, 2025

Cogent reported positive SUMMIT trial data for bezuclastinib in NonAdvSM and plans to file for FDA approval by late 2025.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 07, 2025

Via Benzinga

Quanex Building Products, Manchester United, Byrna Technologies And Other Big Stocks Moving Higher On Friday ↗

June 06, 2025

Via Benzinga

Acelyrin, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

January 07, 2025

Via Benzinga

Analyst Expectations for Cogent Biosciences's Future ↗

December 15, 2023

Via Benzinga

Analyst Expectations for Cogent Biosciences's Future ↗

August 30, 2023

Via Benzinga

$10M Bet On GameStop? Check Out These 3 Stocks Insiders Are Buying ↗

June 14, 2023

Although US stocks closed higher on Tuesday, there were a few notable insider trades.

Via Benzinga

Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket ↗

January 07, 2025

Via Benzinga

COGT Stock Earnings: Cogent Biosciences Misses EPS for Q2 2024 ↗

August 06, 2024

COGT stock results show that Cogent Biosciences missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

COGT Stock Earnings: Cogent Biosciences Misses EPS for Q1 2024 ↗

May 07, 2024

COGT stock results show that Cogent Biosciences missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

April 15, 2024

U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 26, 2024

Via Benzinga

Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 14, 2024

Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financial results and revised guidance above estimates and shared plans to list...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 10, 2024

Via Benzinga

Nasdaq Edges Higher; Macy's Shares Jump ↗

December 11, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 100 points on Monday. The Dow traded up 0.26% to 36,341.44 while the NASDAQ rose 0.12% to 14,421.98. The S&P...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 11, 2023

Via Benzinga

Dow Surges 100 Points; Cogent Biosciences Shares Plunge ↗

December 11, 2023

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.28% to 36,349.22 while the NASDAQ fell 0.36% to 14,352.34. The S&P...

Via Benzinga

Topics Stocks

Cogent Biosciences Shares Fall Despite Positive Clinical Trial Updates For Systemic Mastocytosis Treatment ↗

December 11, 2023

Cogent Biosciences Inc (NASDAQ: COGT) shared data from Part 1 of its ongoing Phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis (AdvSM) at the American Society...

Via Benzinga

Coinbase, Riot Platforms, Marathon Digital And Other Big Stocks Moving Lower On Monday ↗

December 11, 2023

U.S. stocks traded mostly mixed, with the Dow Jones index gaining more than 100 points on Monday. Here are some other big stocks recording losses in today’s session.

Via Benzinga

Topics Stocks

US Stocks Mixed; Cigna Shares Spike Higher ↗

December 11, 2023

U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 20 points on Monday. Following the market opening Monday, the Dow traded up 0.07% to 36,272.54 while the NASDAQ fell...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 11, 2023

Via Benzinga

Unpacking Blueprint Medicines' Ayvakit's Bright Future: Insights From Latest Physician Survey On Sales Predictions ↗

August 21, 2023

Needham slightly increased the price target for Blueprint Medicines Corp (NASDAQ: BPMC) from $65 to $66

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.